With more than 20 years of experience in Marketing & Communications, Heidi brings her expertise for combining words and visuals to The Verden Group and our clients. Combining a strong grasp of both written and verbal communications with a flair for design, Heidi helps clients to deliver their messages in effective and engaging ways.
Whether it’s doing design and layout for ViewPoint, reviewing and editing client websites, or drafting effective and engaging communications pieces, Heidi brings a unique perspective and a wealth of enthusiasm to every project. In addition to her role at The Verden Group, Heidi is a mixed media artist and teacher, offering a variety of workhops to individuals and groups in Halifax, NS. Her current artistic focus is on the healing power of creative art journaling and she is passionate about teaching others how to incorporate this wellness practice into their lives.
A new study shows that a single dose of the Johnson and Johnson COVID-19 vaccine is less effective against Delta. Read more about it here.
"According to a new study which has not yet been peer-reviewed, patients who received the single-dose vaccine showed antibodies with low neutralizing titer compared to the modest neutralization titers found in those who received Pfizer and Moderna’s two-jab regimens. Patients who received the one-shot vaccine may be served by receiving a second dose, ideally one of the two mRNA vaccines."
Have you done a financial well checkup for your pediatric practice? Read PCC's blog on the critical areas to focus on.
"Auditing what services your practice offers and its revenue opportunities provides a clear starting point to begin examining your practice’s pricing. In 2021, the definition of RVUs and their value for E&M codes were changed. One of the fundamental changes that pediatricians haven’t yet grasped is that the RVUs of E&Ms has increased so much that it has lowered revenue in other specialties. By not updating your prices to reflect 2021 RVU values for E&Ms, your practice will be leaving money on the table when insurance payors flip to the new valuing system."